Categories AlphaGraphs, Earnings, Health Care

A visual representation of Trxade Group (MEDS) Q1 2020 earnings

Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the market opens. The bottom-line soared by 44% as platform sales drove the top-line higher by 46%.

Trxade Group Inc. (NASDAQ: MEDS) reported Q1 2020 earnings results

The company continued to expand its trading platform organically, with 305 new independent pharmacies registered in Q1 2020. The average purchases per pharmacy increased on the Trxade platform by 13.7% in the first quarter of 2020, when compared to the same year-ago quarter.

During Q1, the company took strategic measures to enhance its corporate position, uplisting its common stock to the Nasdaq Capital Market and engaging an investor relations firm to implement a comprehensive capital markets strategy.

Take a look at our Health Care articles here

Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top